Ovarian tumour reactive cytotoxic T lymphocytes can recognize peptide determinants on polymorphic epithelial mucins Muc-1
Tumour reactive cytotoxic T lymphocytes (CTL) have been isolated and propagated in culture from tumour infiltrating lymphocytes (TIL) of various tumours [1–6]. The fact that these cells are endowed with the ability to lyse autologous tumour cells has lead to their use in cancer immunotherapy trials, with encouraging results in certain instances .
KeywordsOvarian Tumour Autologous Tumour Core Peptide CaOV3 Cell Lytic Unit
Unable to display preview. Download preview PDF.
- 11.Zotter, S., Hageman, P.C., Lossnitzer, A. et al. (1988) Tissue and tumour distribution of human polymorphic epithelial mucin. Cancer Rev., 11–12, 55–101.Google Scholar
- 12.Gendler, S., Papadimitriou, J., Duhig, T. et al. (1988) A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol Chem., 263, 1282–3.Google Scholar
- 13.Papadimitriou, J.T. and Gendler, S. (1988) Molecular aspects of mucins. Cancer Rev., 11–12, 11–24.Google Scholar
- 18.Parker, K.C., Bednarek, M.A., Hull, L.K. et al. (1992) Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2, J.Immunol, 149, 2580–7.Google Scholar
- 19.Gammon, M.C., Bednarek, M.A., Biddison, W.E. et al. (1992) Endogenous loading of HLA- A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its 26. inhibition by an exogenous peptide antagonist. J.mmunol, 148, 7–12.Google Scholar
- 27.McGuckin, M.A., Wright, G. and Ward, B.G. (1990) Expression of a polymorphic epithelial mucin antigen defined by the monoclonal antibody BC2 in ovarian carcinoma. Use of the BC2 antibody for the detection of micrometastasis. Am. J. Pathol, 96,46–52.Google Scholar
- 31.Lloyd, K.O. (1992) Ovarian Cancer Mucins. Second International Workshop on Carcinoma-associated Mucins, Robinson College, Cambridge, August 2–6.Google Scholar
- 32.Pinn, O.J. (1992) Antigen-specific, MHC- unrestricted T cells. Biotherapy, 4,1239–49.Google Scholar
- 33.Henderson, R.A., Michel, H., Sakaguchi, K. et al. (1992) HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science, 255,126Google Scholar